Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO22467-T1

Drug Field of development:

Obesity Therapy Area:

Product Type of patent:

Gpr50 ligands for use for treating diseases mediated by gpr50

GPR50 (also known as MMR, H9 or ML1X), is an orphan G protein-coupled receptorbelonging to the melatonin receptor family, but which has lost the […]

BIO21307-T1

Drug Field of development:

Obesity Therapy Area:

Method Type of patent:

Chronopharmacoligical use of dhodh inhibitor for thetreatment and

Targeting mitochondrial function is a strategy for preventing metabolic disorders, but restoring mitochondria diurnal regulation remains to be […]

BIO23217-T1

Drug Field of development:

Obesity Therapy Area:

Target Type of patent:

Methods of treatment of metabolic disorders

In the present invention SLC5A9 gene (encoding SGLT4 protein) regulation was analyzed in the intestine of patients before and after weight-loss […]

BIO19224-D1

Biomarker Field of development:

Obesity Therapy Area:

Biomarker Type of patent:

Use of new biomarker for selecting and determining response to

Exercise improves metabolic health and prevents the complications of obesity and type 2 diabetes. The inventors hypothesized that skeletal muscle […]

BIO19113-T1

Drug Field of development:

Obesity Therapy Area:

Method Type of patent:

Use of an agent capable of inhibiting the activation of mait cells for

Obesity is associated with low-grade inflammation in adipose tissue (AT) and dysfunctional adipocytes producing inflammatory molecules. A recent study […]

147

56

310

46

Our Technology Offers

Gpr50 ligands for use for treating diseases mediated by gpr50

Chronopharmacoligical use of dhodh inhibitor for thetreatment and

Methods of treatment of metabolic disorders

Use of new biomarker for selecting and determining response to

Use of an agent capable of inhibiting the activation of mait cells for

You might also be interested in

Mucosal-associated invariant t (mait) cells

Methods of treatment of iron overload associated

Methods of treating iron deficiency-related

Gpr50 ligands for use for treating diseases

Chronopharmacoligical use of dhodh inhibitor for

Use of retinoic acid receptor (rar) agonists

Methods for the treatment of endometriosis

Use of tryptophan hydroxylase 1 (tph1) inhibitors

Use of cd9 as a biomarker and as a biotarget in

Use of inhibitors of the hippo signalling pathway

Bacteroides faecichinchilleae and its use in the

Use of shp2 inhibitors for inhibiting senescence